Enanta Pharmaceuticals Inc (ENTA) — Working Capital to Net Assets Ratio
Enanta Pharmaceuticals Inc (ENTA) has a Working Capital to Net Assets ratio of 147.9% as of June 2026. Working capital of $149.45 Million (current assets of $203.62 Million minus current liabilities of $54.17 Million) is measured against net assets of $101.07 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See ENTA defensive interval ratio to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Enanta Pharmaceuticals Inc Working Capital to Net Assets (2011–2025)
This chart shows how Enanta Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2011 to 2025. As of June 2026, the ratio stands at 147.9%, reflecting working capital of $149.45 Million against net assets of $101.07 Million USD. For the complete balance sheet picture, see Enanta Pharmaceuticals Inc assets under control.
Annual Working Capital to Net Assets for Enanta Pharmaceuticals Inc (2011–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Enanta Pharmaceuticals Inc from 2011 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check financial resilience of Enanta Pharmaceuticals Inc to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 240.7% | $155.78 Million | $64.72 Million | $204.34 Million | $48.55 Million | ▲ +52.6 pp |
| 2024 | 188.1% | $242.32 Million | $128.81 Million | $299.85 Million | $57.53 Million | ▲ +22.0 pp |
| 2023 | 166.1% | $360.00 Million | $216.74 Million | $422.79 Million | $62.79 Million | ▲ +78.4 pp |
| 2022 | 87.7% | $281.89 Million | $321.33 Million | $311.71 Million | $29.83 Million | ▲ +16.9 pp |
| 2021 | 70.8% | $282.85 Million | $399.43 Million | $319.02 Million | $36.17 Million | ▼ -19.8 pp |
| 2020 | 90.6% | $412.68 Million | $455.58 Million | $436.84 Million | $24.16 Million | ▲ +8.6 pp |
| 2019 | 82.0% | $379.24 Million | $462.49 Million | $401.85 Million | $22.61 Million | ▼ -10.6 pp |
| 2018 | 92.6% | $364.36 Million | $393.68 Million | $380.39 Million | $16.02 Million | ▲ +20.7 pp |
| 2017 | 71.9% | $216.84 Million | $301.68 Million | $237.82 Million | $20.98 Million | ▼ -11.2 pp |
| 2016 | 83.1% | $224.27 Million | $269.94 Million | $232.16 Million | $7.89 Million | ▲ +13.7 pp |
| 2015 | 69.4% | $163.94 Million | $236.16 Million | $170.64 Million | $6.70 Million | ▼ 0.0 pp |
| 2014 | 69.4% | $103.23 Million | $148.65 Million | $107.97 Million | $4.75 Million | ▼ -21.3 pp |
| 2013 | 90.7% | $100.19 Million | $110.47 Million | $104.71 Million | $4.53 Million | ▼ -3.9 pp |
| 2012 | 94.6% | $41.57 Million | $43.93 Million | $47.31 Million | $5.73 Million | ▲ +112.0 pp |
| 2011 | -17.4% | $22.95 Million | $-131.96 Million | $25.10 Million | $2.15 Million | — |